Research article · 10 Dec 2025
Research articlePublished 3 May 2017
Oral iron for anaemia in non-dialysis chronic kidney disease. The relationship between hepcidin-25, iron metabolism and inflammation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Hepcidin and inflammatory markers can differentiate patients with chronic kidney disease who respond to oral iron therapy. Objectives: To assess if the answer to iron oral therapy is influenced by hepcidin or by inflammation and to describe the relationship between hepcidin, inflammation and anaemia in patients with non-dialysis chronic kidney disease. Methods: Non-randomized prospective study on a population of non-dialysis chronic kidney disease and anaemia attending a tertiary care hospital. Eligible patients were over 18 years, with no treatment for anaemia and estimated Glomerular Filtration Rate (eGFR)<60 ml/min/1.73 mp at least 6 months before enrolment. Exclusion criteria: bleeding, malignancy, infection, systemic or hepatic disease, immunosuppression, MCV higher than 100 fl, dialysis and renal transplantation. All patients received a four-week treatment with oral iron (Ferrous sulfate) at a dose of 105 mg once daily. Iron metabolism parameters, serum hepcidin-25, IL-6, TNF-α, Erythropoietin (EPO), high-sensitivity CRP were measured at baseline and after four weeks of oral iron therapy. Results: Four weeks of oral iron therapy significantly improved haemoglobin values (p<0.05). Serum hepcidin values were significantly higher after four weeks of oral iron compared with baseline. Hepcidin-25 was positively correlated with ferritin, serum iron, TSAT and TNF-alpha. A negative correlation between hepcidin-25, eGFR and serum EPO was demonstrated. In multivariate regression analysis, TNF-α was the parameter that best predicted hepcidin values. Conclusion: Our results agree that oral iron treatment is effective in raising haemoglobin in non-dialysis CKD patients after four weeks of treatment. Hepcidin seems to be more sensitive than ferritin to confirm the improvement in iron utilization. TNF-α was the best predictor of hepcidin values in our patients.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomedical Research.
Research article · 7 Oct 2025
Multimarker Approach to Assess Glycemic Control and Bone Metabolism in Type 2 Diabetes Mellitus with Potential for Enhanced Clinical Monitoring
Review article · 13 Aug 2025
Inventions in Telemedicine Shaping the Post-Pandemic Landscape: A Complete Review of Its Revolution and Influence in the USA
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomedical Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Carmen Caldararu”
- BylineArticles whose byline prints “Grigore Dogaru”
- BylineArticles whose byline prints “Dorin Ionut Tarta”
- BylineArticles whose byline prints “Adina Hutanu”
- BylineArticles whose byline prints “Maria T Dogaru”
- BylineArticles whose byline prints “Emilian Carasca”
- BylineArticles whose byline prints “Mirela Liana Gliga”
